Navigation Links
Alkermes Announces Positive Results from Phase 1/2 Clinical Study,of ALKS 29

Inc. Alkermes' pipeline includes extended-release injectable, pulmonary, and oral products for the treatment of prevalent, chronic diseases such as central nervous system disorders, addiction and diabetes. Alkermes' headquarters are in Cambridge, Massachusetts, and it operates research and manufacturing facilities in Massachusetts and Ohio.

Certain statements set forth above may constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to statements about Alkermes' addiction portfolio, including its development activities for ALKS 29 and other proprietary product candidates. Although the company believes that such statements are based on reasonable assumptions within the bounds of its knowledge of its business and operations, the forward-looking statements are neither promises nor guarantees and the company's business is subject to significant risk and uncertainties and there can be no assurance that its actual results will not differ materially from its expectations. These risks and uncertainties include, among others: whether future clinical studies of ALKS 29 will confirm previous results; whether the company will pursue continued development of ALKS 29 or other proprietary product candidates for the treatment of addiction, including alcohol dependence; whether the combination of the two agents tested will provide advantages over existing oral medications; whether the company will present data from the phase 1/2 study at a future medical meeting; and decisions by the FDA regarding ALKS 29 or other oral product candidates. For further information with respect to factors that could cause the company's actual results to differ materially from expectations, reference is made to the reports the company filed with the Securities and Exchange Commission under the Securities Exchange Act of 1934, as amended. The company disclaims any intention or responsibility for updating forward
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
2. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
3. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
4. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
5. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
6. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
7. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
8. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
9. Protox Announces Positive Clinical Data from Prostate Cancer Study
10. Inspire Announces Webcast of Presentation at C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
11. NexMed Announces Completion of Patient Enrollment in Two Pivotal Phase 3 Studies for Anti-Fungal Product
Post Your Comments:
(Date:7/24/2014)...  Abaxis, Inc. (NasdaqGS: ABAX ), a ... reported financial results for the first fiscal quarter ended ... , Revenues of $47.5 million, up 10% over last ... up 50% over last year,s comparable quarter. ... million, up 20% over last year,s comparable quarter. ...
(Date:7/24/2014)... VIEW, Calif. , July 24, 2014  IRIDEX ... it will release its second quarter 2014 financial results ... 2014. In conjunction with the release, the Company ... at 5:00 p.m. Eastern Time on ... of the quarter and other business developments. ...
(Date:7/24/2014)... , July 24, 2014 Omnicell, ... provider of medication and supply management solutions and ... call Thursday, July 31, to discuss the Company,s ... Omnicell Second Quarter 2014 earnings conference call and ... PTWho:  , Randall Lipps, chairman, president and chief ...
Breaking Medicine Technology:Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 2Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 3Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 4Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 5Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 6Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 7Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 8Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 9Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 10Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 11Omnicell to Release Second Quarter 2014 Earnings Results on July 31 2
... Biosciences, a privately held company leading the development of ... McDonald, MBA, Senior Vice President and Chief Business Officer, ... will highlight new and innovative cardiovascular drug therapies at ... discussion will be held at the New York Palace ...
... Inc., today announced the expansion of its Nutraficient®, ... high-productivity systems designed specifically for use on food ... European Commission Directive (2010/69/EU), already adopted in the ... certain food supplement products.  The additives now allowed ...
Cached Medicine Technology:Regado Biosciences to Present at the 2011 RBC Capital Markets Healthcare Conference in New York City 2Regado Biosciences to Present at the 2011 RBC Capital Markets Healthcare Conference in New York City 3
(Date:7/25/2014)... Youngstown, Ohio (PRWEB) July 25, 2014 ... processed foods? How to know? , Read the labels! ... labels and determine how it relates to health during ... 12:30 p.m. Aug. 1 at Humility House, 755 Ohltown ... Lackey will lead an informational discussion and answer questions. ...
(Date:7/25/2014)... July 25, 2014 As reported by Wood ... Deaths Increase (7/20), Michigan has seen a nearly 500-person increase ... While the count was 271 between 1999 and 2002, the ... Agents believe that, like other states, drug users in Michigan ... via prescription pills. He compared the price of both substances, ...
(Date:7/25/2014)... (PRWEB) July 25, 2014 The Little ... Fun Fest on Sunday, July 27 at Discovery Green ... include Memorial, Copperfield, Katy, Pearland, Friendswood, Spring, The Woodlands, ... The Heights. , “We’re thrilled to be attending ... said Heather Belcher who owns the Sugarland-Missouri City location. ...
(Date:7/25/2014)... 25, 2014 Art of Facial Surgery has ... those in Toronto who are looking for minor touch-ups to ... done by the American Academy of Facial Plastic and Reconstructive ... in facial plastic surgery showed a surprising increase between 2012 ... percent, while hair transplants increased by 7 percent and eyelid ...
(Date:7/25/2014)... Washington, NY (PRWEB) July 25, 2014 ... protecting the rights of consumers comments on a recent ... widow of a smoker $23.6 billion in punitive damages. ... manufactures Kool brand cigarettes. The case is Cynthia Robinson ... 2008 in the Florida First Circuit Court, Escambia County, ...
Breaking Medicine News(10 mins):Health News:Learn to Decipher Food Labels at Humility House 2Health News:Rise in Heroin Use, Overdose Deaths in Michigan 2Health News:The Little Gym of Houston to Attend Houston Family Magazine’s Family Fun Fest 2014 2Health News:Art of Facial Surgery Responds to Demand for Facial Plastic Surgery Increase Due to the Popularity of Selfies 2Health News:Art of Facial Surgery Responds to Demand for Facial Plastic Surgery Increase Due to the Popularity of Selfies 3Health News:A Florida Jury Awards Widow More Than $23 Billion in Punitive Damages in a Lawsuit Brought Against Tobacco Maker, R.J. Reynolds, Parker Waichman LLP Comments 2Health News:A Florida Jury Awards Widow More Than $23 Billion in Punitive Damages in a Lawsuit Brought Against Tobacco Maker, R.J. Reynolds, Parker Waichman LLP Comments 3
... Software, Inc. today,announced the worldwide launch of iFastrack, ... software for reducing business,risk by tracking insurance certificates ... to manage their risk from,uninsured contractors, vendors or ... proof of insurance at the onset of a ...
... Pa., Aug. 6 The Quigley,Corporation (Nasdaq: QGLY ... to succeed George J. Longo, who will be retiring ... Chief Financial Officer and as a,member of the Board ... and has served in management positions including,Corporate Controller of ...
... Saddleback Church Hosts International AIDS Conference Satellite Session on ... the Partnership of Government, Business & the Church, ... and executive director of the Saddleback HIV/AIDS Initiative,moderated a ... experts; and Saddleback HIV/AIDS Initiative directors; along with,her husband, ...
... software for physician offices, hospitalists and medical billing services, kicked-off ... ... Orlando, FL (PRWEB) August 6, 2008 ... [medical billing software] for physician offices, hospitalists and medical billing ...
... Hospitalized Patient, SCHAFFHAUSEN, Switzerland, Aug. 6 ... to treat,heart failure, announced first use of the ... and Dr. Fabrizio Oliva at Ospedale Niguarda Ca,Granda-Milano, ... to,provide the latest medical technology to treat patients., ...
... ATSI ), manufacturer and marketer of state-of-the-art ... at the Canaccord,Adams 28th Annual Global Growth Conference ... and CEO of ATS Medical, will present at,2:30 ... (Logo: http://www.newscom.com/cgi-bin/prnh/20040202/ATSILOGO ), Attendance at ...
Cached Medicine News:Health News:GG-One Software Announces iFastrack to Help Avoid Insurance Disasters 2Health News:The Quigley Corporation Names Gerard M. Gleeson to Succeed Retiring George J. Longo as Chief Financial Officer and Director 2Health News:Pastor Rick & Kay Warren Bring Together Leaders to Discuss Unification of Expertise to Stop HIV/AIDS: 2Health News:Pastor Rick & Kay Warren Bring Together Leaders to Discuss Unification of Expertise to Stop HIV/AIDS: 3Health News:Pastor Rick & Kay Warren Bring Together Leaders to Discuss Unification of Expertise to Stop HIV/AIDS: 4Health News:CollaborateMD Launches New Value-Added Reseller (VAR) Program 2Health News:Ospedale Niguarda Ca' Granda-Milano Adopts Latest Technology to Treat Patients with Heart Failure 2Health News:ATS Medical to Participate at the 28th Annual Canaccord Adams Global Growth Conference 2
Aplio was designed for intuitive operation so you can get the results you are looking for quickly and easily. From customizable measurement packages to an ergonomic platform design, Aplio was built m...
This catheter is intended for ultrasound examination of coronary intravascular pathology ONLY. Intravascular ultrasound imaging is indicated in patients who are candidates for transluminal coronary i...
Fludeoxyglucose F 18 Injection:, The PETNET SafetyNET: 99% On-Time Delivery of MetaTrace FDG , Largest Cyclotron - Equipped Radiopharmacy Network , 39 MetaTrace FDG producing sites , Customi...
... The AB Holter, a ... system, provides sophisticated,ambulatory ECG analysis ... Windows environment.,Designed to use Windows ... the system allows,the option of ...
Medicine Products: